- Home
- Publications
- Publication Search
- Publication Details
Title
Drug repurposing for the treatment of glioblastoma multiforme
Authors
Keywords
Drug repurposing, Drug repositioning, Glioblastoma multiforme, Cancer treatment, High-throughput technologies, Signal transduction, Energy metabolism
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 36, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-11-28
DOI
10.1186/s13046-017-0642-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular markers in glioma
- (2017) Kirsten Ludwig et al. JOURNAL OF NEURO-ONCOLOGY
- Clinical chemoproteomics—Opportunities and obstacles
- (2017) Lyn H. Jones et al. Science Translational Medicine
- Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1 -mutated or IDH2 -mutated solid tumours
- (2017) Remco J Molenaar et al. BMJ Open
- Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer
- (2016) Randy Strong et al. AGING CELL
- Biocomputing drug repurposing toward targeted therapies
- (2016) Luca Cardone Aging-US
- Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
- (2016) C. Coyle et al. ANNALS OF ONCOLOGY
- The anti-tumour agent lonidamine is a potent inhibitor of the mitochondrial pyruvate carrier and plasma membrane monocarboxylate transporters
- (2016) B. Nancolas et al. BIOCHEMICAL JOURNAL
- Mechanism of antineoplastic activity of lonidamine
- (2016) Kavindra Nath et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells
- (2016) Sonam Dolma et al. CANCER CELL
- An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer
- (2016) Lianfeng Wu et al. CELL
- SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for Inhibition
- (2016) Cristina Talarico et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082)
- (2016) W. Wick et al. CLINICAL CANCER RESEARCH
- Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma
- (2016) X. Lun et al. CLINICAL CANCER RESEARCH
- Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy
- (2016) Zhiyu Wang et al. CURRENT DRUG TARGETS
- Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies
- (2016) Steve Pascolo EUROPEAN JOURNAL OF PHARMACOLOGY
- Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy Balance
- (2016) Ahmed M. Hegazy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting autophagy to sensitive glioma to temozolomide treatment
- (2016) Yuanliang Yan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Can you teach old drugs new tricks?
- (2016) Nicola Nosengo NATURE
- Perspective: The precision-oncology illusion
- (2016) Vinay Prasad NATURE
- AMPK promotes tolerance to Ras pathway inhibition by activating autophagy
- (2016) S Sanduja et al. ONCOGENE
- Target identification with quantitative activity based protein profiling (ABPP)
- (2016) Xiao Chen et al. PROTEOMICS
- Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds
- (2016) Diego Carrella et al. Oncotarget
- Toward Repurposing Metformin as a Precision Anti-Cancer Therapy Using Structural Systems Pharmacology
- (2016) Thomas Hart et al. Scientific Reports
- 13C MRS and LC–MS Flux Analysis of Tumor Intermediary Metabolism
- (2016) Alexander A. Shestov et al. Frontiers in Oncology
- Metformin in Cancer Treatment and Prevention
- (2015) Daniel R. Morales et al. Annual Review of Medicine
- Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial
- (2015) K. L. Bride et al. BLOOD
- Genetic Classification of Gliomas: Refining Histopathology
- (2015) Michael B. Foote et al. CANCER CELL
- The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells
- (2015) Seung Woo Lee et al. CANCER LETTERS
- Targeting a Plk1-Controlled Polarity Checkpoint in Therapy-Resistant Glioblastoma-Propagating Cells
- (2015) R. G. Lerner et al. CANCER RESEARCH
- Impact of Autophagy Inhibition at Different Stages on Cytotoxic Effect of Autophagy Inducer in Glioblastoma Cells
- (2015) Chenguang Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- SI113, a Specific Inhibitor of the Sgk1 Kinase Activity that Counteracts Cancer Cell Proliferation
- (2015) Lucia D''Antona et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma
- (2015) A. L. Di Stefano et al. CLINICAL CANCER RESEARCH
- Role of autophagy in the maintenance and function of cancer stem cells
- (2015) Ilio Vitale et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine
- (2015) Lili Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment
- (2015) Kazuhiro Tanaka et al. JOURNAL OF CLINICAL INVESTIGATION
- Adaptive Mitochondrial Reprogramming and Resistance to PI3K Therapy
- (2015) Jagadish C. Ghosh et al. JNCI-Journal of the National Cancer Institute
- Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors
- (2015) Encouse B. Golden et al. Neurosurgical Focus
- Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
- (2015) Mona Meyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The energy blockers bromopyruvate and lonidamine lead GL15 glioblastoma cells to death by different p53-dependent routes
- (2015) Magdalena Davidescu et al. Scientific Reports
- Adaptive Mitochondrial Reprogramming and Resistance to PI3K Therapy
- (2015) Jagadish C. Ghosh et al. JNCI-Journal of the National Cancer Institute
- Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide
- (2015) Joanna Triscott et al. Oncotarget
- A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
- (2014) Myrna R Rosenfeld et al. Autophagy
- Acetate Is a Bioenergetic Substrate for Human Glioblastoma and Brain Metastases
- (2014) Tomoyuki Mashimo et al. CELL
- Chloroquine potentiates temozolomide cytotoxicity by inhibiting mitochondrial autophagy in glioma cells
- (2014) Yusuke S. Hori et al. JOURNAL OF NEURO-ONCOLOGY
- Hexokinase-II Positively Regulates Glucose Starvation-Induced Autophagy through TORC1 Inhibition
- (2014) David J. Roberts et al. MOLECULAR CELL
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin
- (2014) Kavindra Nath et al. NMR IN BIOMEDICINE
- Application of molecular technologies for phosphoproteomic analysis of clinical samples
- (2014) M Pierobon et al. ONCOGENE
- Chloroquine in Cancer Therapy: A Double-Edged Sword of Autophagy
- (2013) T. Kimura et al. CANCER RESEARCH
- The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt/mTOR pathway in human U-87MG glioma cells
- (2013) Soon Young Shin et al. CARCINOGENESIS
- Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage
- (2013) A. Paranjpe et al. CARCINOGENESIS
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Rapalogs and mTOR inhibitors as anti-aging therapeutics
- (2013) Dudley W. Lamming et al. JOURNAL OF CLINICAL INVESTIGATION
- mTOR is a key modulator of ageing and age-related disease
- (2013) Simon C. Johnson et al. NATURE
- The integrated landscape of driver genomic alterations in glioblastoma
- (2013) Veronique Frattini et al. NATURE GENETICS
- An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
- (2013) D. Rohle et al. SCIENCE
- Genomic Medicine: A Decade of Successes, Challenges, and Opportunities
- (2013) J. J. McCarthy et al. Science Translational Medicine
- Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells
- (2012) P Liu et al. BRITISH JOURNAL OF CANCER
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- Hypoxia-Induced Autophagy Promotes Tumor Cell Survival and Adaptation to Antiangiogenic Treatment in Glioblastoma
- (2012) Y.-L. Hu et al. CANCER RESEARCH
- In silico drug repositioning – what we need to know
- (2012) Zhichao Liu et al. DRUG DISCOVERY TODAY
- Transcriptional data: a new gateway to drug repositioning?
- (2012) Francesco Iorio et al. DRUG DISCOVERY TODAY
- Aldehyde dehydrogenase 1A1—a new mediator of resistance to temozolomide in glioblastoma
- (2012) Andrea Schäfer et al. NEURO-ONCOLOGY
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma
- (2012) D. Singh et al. SCIENCE
- Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
- (2012) Michael N. Pollak Cancer Discovery
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Lonidamine Extends Lifespan of Adult Caenorhabditis elegans by Increasing the Formation of Mitochondrial Reactive Oxygen Species
- (2011) S. Schmeisser et al. HORMONE AND METABOLIC RESEARCH
- Metabolic Alterations in Highly Tumorigenic Glioblastoma Cells
- (2011) Yunfei Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time
- (2010) David E. Gerber et al. CANCER CELL
- Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity
- (2010) M. Rasper et al. NEURO-ONCOLOGY
- ArrayExpress update--an archive of microarray and high-throughput sequencing-based functional genomics experiments
- (2010) H. Parkinson et al. NUCLEIC ACIDS RESEARCH
- Discovery of drug mode of action and drug repositioning from transcriptional responses
- (2010) F. Iorio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Network analyses in systems pharmacology
- (2009) S. I. Berger et al. BIOINFORMATICS
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- GeneSigDB—a curated database of gene expression signatures
- (2009) Aedín C. Culhane et al. NUCLEIC ACIDS RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started